−2.8926 USD
−7.10 M USD
0.00 USD
3.10 M
About GlucoTrack, Inc.
Sector
Industry
CEO
Paul V. Goode
Website
Headquarters
Rutherford
Founded
2001
FIGI
BBG0025SKQ53
GlucoTrack, Inc. designs, develops, and commercializes non-invasive glucose monitoring devices for use by persons suffering from diabetes. The company offers the GlucoTrack model DF-F glucose monitoring device, which utilizes a patented combination of ultrasound, electromagnetic and thermal technologies to obtain glucose measurements in less than one minute via a small sensor that is clipped onto one's earlobe and connected to a small, handheld control and display unit, all without drawing blood or interstitial fluid. It was designed to help people with diabetes and pre-diabetics obtain glucose level readings without the pain. The company was founded by Avner Gal and David Malka in September 2001 and is headquartered in Rutherford, NJ.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of GCTK is 0.2599 USD — it has increased by 4.00% in the past 24 hours. Watch GlucoTrack, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange GlucoTrack, Inc. stocks are traded under the ticker GCTK.
GCTK stock has fallen by −13.65% compared to the previous week, the month change is a −87.86% fall, over the last year GlucoTrack, Inc. has showed a −71.19% decrease.
GCTK reached its all-time high on Jul 22, 2013 with the price of 650.0000 USD, and its all-time low was 0.2160 USD and was reached on Nov 21, 2024. View more price dynamics on GCTK chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
GCTK stock is 9.85% volatile and has beta coefficient of 1.10. Track GlucoTrack, Inc. stock price on the chart and check out the list of the most volatile stocks — is GlucoTrack, Inc. there?
Today GlucoTrack, Inc. has the market capitalization of 1.50 M, it has decreased by −7.85% over the last week.
Yes, you can track GlucoTrack, Inc. financials in yearly and quarterly reports right on TradingView.
GCTK net income for the last quarter is −5.09 M USD, while the quarter before that showed −4.49 M USD of net income which accounts for −13.32% change. Track more GlucoTrack, Inc. financial stats to get the full picture.
No, GCTK doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 24, 2024, the company has 6.00 employees. See our rating of the largest employees — is GlucoTrack, Inc. on this list?
Like other stocks, GCTK shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GlucoTrack, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GlucoTrack, Inc. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GlucoTrack, Inc. stock shows the strong sell signal. See more of GlucoTrack, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.